Compare Illumina, Inc. (ILMN) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Illumina, Inc. trades at $190.08 (market cap $27.94B), while T-Rex 2X Long MSTR Daily Target ETF trades at $2.13. The key difference: Illumina, Inc. is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| ILMN | MSTU | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $194.33 | $92.70 |
52-Week Low | $91.00 | $1.46 |
Enterprise Value | $29.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
MSTU, a 2x leveraged ETF tracking MicroStrategy, trades at $1.98 with a 6.45% daily gain but remains in a severe long-term downtrend, having lost over 95% in the past year. Technical indicators are bearish, with moving averages signaling strong selling pressure. The fund's performance is directly tied to MicroStrategy's stock, which is heavily influenced by Bitcoin price volatility, and recent news highlights extreme investor losses and high-risk nature of leveraged products.
The outlook for MSTU is highly speculative and risky, with potential for parabolic gains if Bitcoin surges but extreme downside risk during volatility. Investment suitability is limited to aggressive traders comfortable with total loss potential, given the fund's decay mechanisms and dependency on crypto market sentiment rather than traditional fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
